Zeesan
Company

Last deal

$10M

Amount

Post-IPO Equity

Stage

07.06.2021

Date

4

all rounds

$17.4M

Total amount

General

About Company
Zeesan is a biomedical company that focuses on developing and producing molecular diagnostics kits.

Industry

Sector :

Subsector :

Keywords :

Also Known As

致善生物, 厦门致善生物科技股份有限公司, Zhishan Shengwu

founded date

12.06.2010

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

They are dedicated to creating and promoting top-notch products for molecular diagnostics, utilizing advanced PCR technology. Zeesan has introduced innovative platforms like "Multicolor Melting Curve Analysis," "Magnetic Bead (MB)-based Nucleic Acid Extraction Platform," and "Automatic Instrumentation Integration Platform." These platforms address various gaps in the domestic PCR market, providing comprehensive solutions for molecular diagnostics. With their expertise in developing and manufacturing diagnostic kits, instruments, and reagents, Zeesan aims to advance the field of molecular diagnostics and offer the best possible products in the industry.
Contacts